Serobeskyttelsesforholdet (andelen af personer der når et serobeskyttende niveau anti- HBs > 10 mIE/ ml) var upåvirket (96, 5% ved samtidig vaccination, og 97, 5% ved hepatitis B vaccine alene).
The seroprotection rates (proportion of subjects reaching seroprotective level anti-HBs > 10 mIU/ ml) were unaffected (96.5% for concomitant vaccination and 97.5% for hepatitis B vaccine only).